Gyre Therapeutics Inc (GYRE)

Cost of Revenue

$2.21M

Quarterly · Period ending: · USD

GYRE logo

GYRE Cost of Revenue

Latest reported$2.21M
GYRE Quarterly Cost of Revenue ($22.58K → $2.21M)
High-resolution chart · PNG

GYRE cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,209,000
1,227,000
1,743,000
1,628,000
1,151,000
894,000
1,177,000
958,000
770,000
979,000
1,250,000
1,184,000
1,077,000
1,125,000
1,360,862
1,392,466
67,000
911,000
2,454,000
2,392,000
1,184,000
1,480,000
2,076,000
911,000
1,742,000
4,479,000
34,000
9,927,000
11,111,000
12,027,000
8,239,000
5,575,000
3,889,000
3,771,000
28,871,000
3,805,000
28,711,000
27,371,000
2,112,000
3,396,000
2,752,000
2,286,000
1,766,000
1,486,000
134,000
1,383,000
1,396,000
1,336,000
1,287,000
1,247,964
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,350,000
206,000
258,000
228,000
184,226
183,620,000
177,677,000
203,477,000
171,495
173,304,000
205,134,000
165,491
156,688
131,951,000
-22,332
190,947,000
237,111
123,466
97,781
22,575
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.